Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Morris

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Gynecologic Oncology|February 14, 2015
The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional studyIra Winer, Isabel Alvarado-Cabrero, Oudai Hassan, et al.
Gynecologic Oncology Reports|October 13, 2025
Impact of molecular and immune signature on endometrial biopsies with atypical hyperplasia with and without concurrent endometroid carcinomaTerrence Wong, Joellen Fresia, Nicholas Adzibolosu, et al.
Pharmaceutical Research|August 6, 2011
MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹)Assaad Semaan, Aamer M Qazi, Shelly Seward, et al.
Frontiers in Immunology|July 12, 2023
Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancerNicholas Adzibolosu, Ayesha B Alvero, Rouba Ali-Fehmi, et al.
Molecular Therapy. Oncology|September 18, 2024
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancerGhassan M Saed, Nicole M Fletcher, Harvey Sharma, et al.
Gynecologic Oncology|February 19, 2025
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysisAyesha B Alvero, Sharon Wu, Alex Farrell, et al.
Molecular Cell|August 18, 2022
Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progressionIoannis Sanidas, Hanjun Lee, Purva H Rumde, et al.
Nature Communications|June 30, 2019
SETD1A protects from senescence through regulation of the mitotic gene expression programKen Tajima, Satoru Matsuda, Toshifumi Yae, et al.
Nature Communications|September 24, 2015
SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genesKen Tajima, Toshifumi Yae, Sarah Javaid, et al.
Gynecologic Oncology|April 30, 2022
Molecular profiles of endometrial cancer tumors among Black patientsAnnelise M Wilhite, Yasmine Baca, Joanne Xiu, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Gynecologic Oncology|February 14, 2015
The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional studyIra Winer, Isabel Alvarado-Cabrero, Oudai Hassan, et al.
Gynecologic Oncology Reports|October 13, 2025
Impact of molecular and immune signature on endometrial biopsies with atypical hyperplasia with and without concurrent endometroid carcinomaTerrence Wong, Joellen Fresia, Nicholas Adzibolosu, et al.
Pharmaceutical Research|August 6, 2011
MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹)Assaad Semaan, Aamer M Qazi, Shelly Seward, et al.
Frontiers in Immunology|July 12, 2023
Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancerNicholas Adzibolosu, Ayesha B Alvero, Rouba Ali-Fehmi, et al.
Molecular Therapy. Oncology|September 18, 2024
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancerGhassan M Saed, Nicole M Fletcher, Harvey Sharma, et al.
Gynecologic Oncology|February 19, 2025
Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysisAyesha B Alvero, Sharon Wu, Alex Farrell, et al.
Molecular Cell|August 18, 2022
Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progressionIoannis Sanidas, Hanjun Lee, Purva H Rumde, et al.
Nature Communications|June 30, 2019
SETD1A protects from senescence through regulation of the mitotic gene expression programKen Tajima, Satoru Matsuda, Toshifumi Yae, et al.
Nature Communications|September 24, 2015
SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genesKen Tajima, Toshifumi Yae, Sarah Javaid, et al.
Gynecologic Oncology|April 30, 2022
Molecular profiles of endometrial cancer tumors among Black patientsAnnelise M Wilhite, Yasmine Baca, Joanne Xiu, et al.
Pageof 19